Acadia Healthcare Company (ACHC) Stock Analysis & Winston Score
Acadia Healthcare runs a network of behavioral health facilities across the United States and the United Kingdom. These facilities treat people struggling with mental health conditions, substance use disorders, and eating disorders. Acadia is one of the largest standalone behavioral health companies in the US, operating inpatient psychiatric hospitals, residential treatment centers, and outpatient clinics. The company earns money by charging for patient care, with most payments coming from government programs like Medicaid and Medicare, as well as private insurance. Acadia operates roughly 250 facilities and generates around $3 billion in annual revenue. Its scale and the high cost of building new psychiatric facilities give it some competitive advantage, but the business depends heavily on government reimbursement rates, which can change. The key growth driver is rising demand for behavioral health services, though the company also faces ongoing scrutiny over patient care standards and legal investigations into its billing and treatment practices.
Winston Score: 20/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (5/30)
- Growth: Weak (3/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Good (8/15)
Key Facts
Price: $27.82
Market Cap: $2.6B
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: NASDAQ


